// App-Quantinova.ai

: Outcomes of stable coronary artery disease worldwide. Insights from the CLARIFY registry

Researchers

Presenter

  • E Sorbets

Principal Investigators

  • N Greenlow

  • I Ford

  • M Tendera

  • R Ferrari

  • J C Tardif

  • N Danchin

  • S Shalnova

  • P Kalra

Medical Centers

  • Hospital Avicenne of Bobigny, Cardiology and Paris 13 University, Bobigny, France

  • University of Glasgow, Robertson Centre for Biostatistics, Glasgow, United Kingdom

  • Medical University of Silesia, Division of Cardiology and Structural Heart Diseases, Katowice, Poland

  • University Hospital of Ferrara, Cardiology and LTTA centre, Ferrara, Italy

  • Montreal Heart Institute, Cardiology and Research Centre, Montreal, Canada

  • Peking University Peoples' Hospital, Heart institute, Beijing, China People's Republic of

  • European Hospital Georges Pompidou, Centre IPC, Paris, France

  • National Research Center for Preventive Medicine, Moscow, Russian Federation

  • Portsmouth Hospital NHS Trust, Portsmouth, United Kingdom

Locations

  • France

  • United Kingdom

  • Poland

  • Italy

  • Canada

  • Russia

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A